Board of Directors
Richard Burstein Richard Burstein is a real estate attorney who represents and counsels national and regional commercial real estate developers and tenants throughout the United States. With more than 40 years of experience, he counsels on transactions, investments and the development of regional and community shopping centers, office complexes and industrial parks, urban redevelopment projects, multifamily residential developments and the structuring and creation of real estate investment trusts. Richard is recognized as a top laywer in the first tier of lawyers in the real estate field in Michigan by Chambers USA.
Denny Cherette Denny Cherette began his real estate career in 1977 and founded his first real estate firm in 1982. After selling that to a large development group, he founded Investment Property Associates (IPA) in 1985, where he served as president and partner for more than 26 years. In 1993, he co-founded IPA Management to oversee the company’s growing portfolio. Under his leadership, IPA and IPA Management grew to more than 130 employees with operations throughout Western Michigan and Phoenix, Arizona. Primary services included developing properties for the company's portfolio, third-party fee-based development, fee-based real estate strategic planning and consulting, and full service property management for multifamily and commercial properties. In early 2012, Denny left IPA and IPA Management to establish Cherette Group. By that time, IPA’s portfolio had grown to more than five million square feet owned and/or managed. Denny has been involved in the leadership of many community organizations including chairman of the board of the Global Business Leadership Center, chairman of the board of Mercy General Health Partners, chairman of the Economic Development Corporation of the City of Grand Haven, Michigan; and he is also a founding member, and member of the board of directors for the Osteopathic Foundation of West Michigan.
Shelia Crowley, PhD., R.N. Dr. Sheila Crowley is a registered nurse with 35 years of cancer nursing experience, specializing in adult oncology practice. She began her career at the University of Chicago Hospitals and Clinics as a nurse clinician for the GI oncology patient population, followed by a position as the director of critical care nursing at Greater Southeast Community Hospital in Washington, D.C. Dr. Crowley continued her cancer nursing focus at the University of Michigan Health System in positions including oncology clinical nurse specialist, director of patient care services, and most recently as director of the Adult Cancer Survivorship Program at the U-M Comprehensive Cancer Center (UMCCC). She held an adjunct faculty position at the U-M School of Nursing. After concluding her professional career, Dr. Crowley has been a community activist and volunteer. She has served on community boards in Ann Arbor including the Arbor Hospice board of directors and the University Musical Society Advisory Committee. Dr. Crowley is an active volunteer at the Family Learning Institute and has been an active supporter of the UMCCC. She is the administrator for the Crowley Scholarship Fund at the Jackson Community Foundation. Dr. Crowley received her undergraduate degree at Nazareth College in Kalamazoo, Michigan and graduate degrees from the University of Maryland (MS) and the U-M (Ph.D.). She is married, a mother of two, and a grandmother of one.
Frances FarleyDr. Frances Farley is the Robert N. Hessinger Collegiate Professor of Orthapedic Surgery and chief of Pediatric Orthopaedic Surgery at the University of Michigan and assistant surgeon-in-chief of C.S. Mott Children’s Hospital. Her interests are congenital scoliosis, cervical spine, and pediatric trauma. Dr. Farley received her B.A. from Duke University and received her M.D. from Cornell University. She did her residency at the U-M and a fellowship at Texas Scottish Rite Hospital. She served on the board of directors of the American Academy of Orthopaedic Surgeons. She currently serves as the treasurer of the Pediatric Orthopaedic Society of North America.
Jeffrey Gaier is managing partner of the Wealth Planning Resources Group, LLC, a national private wealth practice based in Florham Park, New Jersey. As an attorney and certified financial planner, also certified in long-term care, Mr. Gaier has specialized since 1983 in the financial services profession, primarily in the areas of estate and philanthropic planning. He also counsels individuals and business entities on retirement plan design and executive compensation. Mr. Gaier is admitted to practice law in New York and New Jersey, as well as the United States Tax Court. He also holds series 7 & 63 investment licenses, along with certifications in life, disability, and long-term care insurance. Previously, Mr. Gaier served as a trust and estate manager and senior vice president with Merrill Lynch Trust Company, based at the firm's world headquarters in New York. Prior to joining Merrill Lynch, Mr. Gaier headed the Wealth Planning Strategies Group for Bankers Trust Private Banking, also in New York. Earlier in his career, Mr. Gaier was trained as a tax attorney with the Personal Financial Services (PFS) Group at Coopers & Lybrand, LLP (now PricewaterhouseCoopers). Mr. Gaier also served as law clerk to the Honorable Joseph C. Small of the Tax Court of New Jersey. Mr. Gaier lives in Livingston, New Jersey with his wife Sherry, and two daughters, Jillian and Dana. Jeffrey Gaier, Esq.
Bruce Gershenson, founder of Gershenson Realty and Investment, is a recognized expert in commercial retail development. Mr. Gershenson began his career working with his father, uncle and brothers developing shopping centers. In 1972 he became a principal in Ramco-Gershenson, Inc., and was directly responsible for identifying development opportunities, land acquisition, and brokerage for the company. In 1996, Mr. Gershenson became executive vice president and treasurer of Ramco-Gershenson Properties Trust, a newly formed real estate investment trust traded on the New York Stock Exchange. He also became president of Ramco-Gershenson, Inc., the management subsidiary of Ramco-Gershenson Properties Trust. His chief role with the company was head of the acquisition department, which was responsible for acquiring 24 centers in three years. Mr. Gershenson founded Gershenson Realty and Investment in 2001 and brings to the Company his many years of experience and knowledge. He has an undergraduate degree from The University of Michigan, as well as a Juris Doctorate degree from Wayne State University. Bruce Gershenson
Scott Henderson is the president and chief operating officer for Living Essentials, the owner of 5 Hour ENERGY. He joined 5 Hour ENERGY in early 2006 when it was a $3 Million brand. Prior to joining 5-Hour ENERGY, Scott spent nearly six years in various executrive roles at Handleman Company, a Fortune 1000 company, and as the leading category manager for prerecorded music sales to national retailers. Prior to Handleman, Scott founded and served as President of the Atwater Block Brewery, a microbrewery in Detroit, MI. Before Atwater he lived in Boston where he was a Consultant with Coopers & Lybrand's Financial Advisory Services group where he focused on mergers & acquisitions and corporate restructuring work for middle market companies located throughout the United States. Scott earned both his BS and MBA degrees from the University of Michigan in Ann Arbor. Scott Henderson
Geoff Kasselman is an executive managing director at Newark Grubb Knight Frank's Chicago office, where he leads the company's North American Industrial Practice. In this capacity, Mr. Kasselman guides the direction and expansion of the firm's industrial brokerage capabilities across North America, including supporting various data center projects and promoting the benefits of sustainability, technology and innovation for the sector. Prior to joining NGKF, Mr. Kasselman served as the founder and CEO of Op2mize, a commercial real estate firm that bundled real estate services with best practices in energy efficiency and technology. Among other professional credentials, Mr. Kasselman holds the SIOR, LEED AP, and Cisco Systems registered partner designations and was recently elected as the SIOR vice president, to serve as president beginning the fall of 2016. Mr. Kasselman graduated from the University of Michigan and remains active in their alumni association, previously serving as an executive board member. Mr. Kasselman currently resides in Chicago with his wife and two children. Geoff Kasselman
Sheila Sky Kasselman was diagnosed with early stage pancreas cancer in 2007. She underwent chemotherapy, radiation and a complete Whipple surgery. Six months into recovery she began Sky Foundation, Inc. with the mission to raise awareness and fund early detection research for pancreas cancer. Since its inception, Sky Foundation has proudly donated $765,000 in seed money to several researchers and institutions. Sky continues to expand its network of supporters in the United States and Canada. Prior to starting Sky Foundation, Sheila had a long career in the insurance industry as well as owning her own fi nancial services business. Sheila has three children and four grandchildren. She enjoys active walks, Pilates, gardening, and a challenging game of bridge. Sheila Sky Kasselman
Linda Larin is the associate hospital director for cardiovascular and neuroscience programs and the chief administrative officer of the University of Michigan Frankel Cardiovascular Center. She is a fellow of the American College of Cardiovascular Administrators (AACA), immediate past chair of the American Academy of Medical Administrators (AAMA), and fellow of the American College of Healthcare Executives (ACHE). She is also the recently published editor of a healthcare management book on patient and family centered care, released in November 2013 titled, Inspired to Change-Improving Patient Care One Story at a Time. Linda Larin, F.A.C.C.A., F.A.C.H.E., M.B.A.
Steve Lefkofsky, J.D.Steve is a litigation and business attorney practicing at Lefkofsky and Gorosh in Farmington Hills, Michigan, which he founded in 1994. He and his wife Melanie live in West Bloomfield with their three children. Steve is a passionate sup- porter of University of Michigan and University of Michigan Health System.
Richard Rogel of Avon, Colorado, is the former chairman and chief executive officer of the Preferred Provider Organization of Michigan. Born in Essex, New Jersey, Mr. Rogel earned a Bachelor of Business Administration from the University of Michigan. He was valedictorian of the 1970 Business School class, and he is a former president of the U-M's Alumni Association. Mr. Rogel currently serves on the U-M Health System Advisory Group, and this Pancreatic Advisory Group. During our last university campaign, The Michigan Difference, Mr. Rogel served as chair. Mr. Rogel is also a member of President Mark Schlissel's advisory group, the University Musical Society Senate, the Social Work Development Committee Campaign Taskforce, the Advisory Board of the Samuel Zell and Robert H. Lurie Institute for Entrepreneurial Studies, the Greater Detroit Leadership Gift Committee, the Director's Cabinet in the Department of Intercollegiate Athletics, the Health System Task Force, and the Board of Directors of the Alumni Association. Mr. Rogel is a member of the American Association of Preferred Provider Organization, the American Preferred Health Networks, the American Hospital Association, and the Greater Detroit Health Council. He is the non- operating chairman of CoolSavings.com and director of Quelsys, Incorporated. Mr. Rogel also serves as a director of the Michigan Cancer Foundation. Richard Rogel
Marc is a graduate of the University of Michigan. As a junior, in 1989, Marc started the "karaoke" concept at bars on Campus. This business morphed into a meeting and event business which became an "INC. 500" fastest growing company in 1996. While Marc remains Chairman of Pulse 220, in 2002, he left this business operationally and joined his family business. Marc is a senior managing director with Schechter Wealth, a boutique third generation wealth advisory firm. Marc has been guiding wealthy families on financial matters including; institutional quality investment advisory services, advanced life insurance planning, income and estate taxes, business succession, and charitable planning. Marc Schechter, C.L.U.
Marvin Tepper is a partner at Sterling Equities. He has over 30 years of experience in legal, finance, tax, and investment matters. Prior to Sterling, Mr. Tepper was a senior partner in a New York law fi rm where he built an extensive practice in real estate, corporate, and commercial matters. He served as secretary of PathoGenesis Corporation. Mr. Tepper is the chairman of the Board of Zoning and Appeals of the Village of Sands Point and participates in various other civic and philanthropic organizations. He is a member of the investment committee at Sterling American Property, Inc. Mr. Tepper received a law degree from New York University's School of Law and an A.B. degree from NYU. Marvin B. Tepper
Dr. Max Wicha is the founding director of the University of Michigan Comprehensive Cancer Center (UMCCC) who stepped down as the acting director in 2015. He is also a distinguished professor of Oncology. Under his direction for more than 27 years, the UMCCC established itself as a national leader. It currently receives more funding from the National Cancer Institute than any other university-based center. Dr. Wicha is also a leader in breast cancer research and has been a pioneer in the field of cancer stem cells. According to the science citation index, he is the most highly cited investigator in this field. Dr. Wicha's group was part of the team that first identified cancer stem cells in human breast cancers, the first in any solid tumor. His laboratory has developed most of the techniques and assays used to study these cells and to elucidate the pathways which regulate their behavior. These pathways have provided targets for the development of drugs aimed at targeting cancer stem cells. The UMCCC has established itself as a world leader in cancer stem cell biology and therapeutics and is currently conducting nine early phase clinical trials aimed at targeting cancer stem cells, the most of any center in the world. Dr. Wicha is co-founder of OncoMed Pharmaceuticals, a biotech technology company focused on developing cancer stem cell therapeutics, which has produced three agents currently in clinical testing. Dr. Wicha is also a practicing clinician whose practice is focused on women with breast cancer. He also serves on advisory boards of eight National Cancer Institute cancer centers and several biotechnology companies. Max Wicha, M.D.